IM Cannabis Corp. Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

DERIVATIVE WARRANTS LIABILITIES AND PREFUNDED WARRANTS - Disclosure of detailed information about reconciliation of the total fair value of derivative warrants liabilities (Details)

DERIVATIVE WARRANTS LIABILITIES AND PREFUNDED WARRANTS - Disclosure of detailed information about reconciliation of the total fair value of derivative warrants liabilities (Details) $ in Thousands			12 Months Ended
	Nov. 12, 2026 $ / shares	Nov. 12, 2024 $ / shares	Dec. 31, 2025 CAD ($)	Dec. 31, 2024 CAD ($)	Dec. 31, 2023 CAD ($)
Disclosure of detailed information about financial instruments [line items]
Balances at beginning of period			$ 887	$ 38	$ 8
Issued				1,154	7,253
Changes in fair value			(286)	(305)	(7,223)
balances at ending of period			601	887	38
Weighted average exercise price of other equity instruments granted in share-based payment arrangement \| $ / shares	$ 3.43	$ 4.32
Series 2024 \| Derivative warrants liabilities
Disclosure of detailed information about financial instruments [line items]
Balances at beginning of period			787	0	0
Issued				1,154	0
Changes in fair value			(186)	(367)	0
balances at ending of period			601	787	0
Series 2023 \| Derivative warrants liabilities
Disclosure of detailed information about financial instruments [line items]
Balances at beginning of period			100	38	0
Issued				0	7,253
Changes in fair value			(100)	62	(7,215)
balances at ending of period			0	100	38
Series 2021 \| Derivative warrants liabilities
Disclosure of detailed information about financial instruments [line items]
Balances at beginning of period			0	0	8
Issued				0	0
Changes in fair value			0	0	(8)
balances at ending of period			$ 0	$ 0	$ 0

- Definition

The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as ‘an accounting mismatch’) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity’s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities]

+ References + Details